EUVIMEDEUVIMED entdecken
Crossref

Engineered Polymeric Nanoparticles Based on Arylated Polyethylenimine Enable Spleen-Selective mRNA Delivery

Hongqian Zhang iD, Dongshan Chen, Song Xue, Zhengping Liu, Xuehua Yang, Cong Zhang, Dawei Li, Daizhou Zhang

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Hongqian Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Academy of Pharmaceutical Sciences, Jinan 250101, China. Hauptthemen laut MEDLINE: Polyethyleneimine, RNA, Messenger, Nanoparticles, Spleen. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Department of Science and Technology of Shandong Province, Postdoctoral Innovation Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonviral vectors hold great promise for mRNA (mRNA)-based therapeutics. However, achieving organ-selective mRNA delivery after systemic administration remains a major challenge. Herein, we engineered hydrophobized polymeric nanoparticles (PNPs) derived from arylated polyethylenimine (PEI) for efficient and organ-selective mRNA delivery. Nine new hydrophobized polymers were synthesized by grafting 2-phenylethyl acrylate (PA) onto PEI with three different molecular weights of PEI and three PA-to-PEI feeding molar ratios. The resulting PNPs were systematically evaluated for mRNA delivery both in vitro and in vivo. Through in vitro transfection screening, three optimal candidates (6PP3-PNP, 12PP6-PNP, and 24PP12-PNP) were selected for systemic mRNA delivery studies in mice. Remarkably, 6PP3-PNP preferentially delivered mRNA to the spleen, in contrast to the liver tropism observed with 12PP6-PNP and 24PP12-PNP. Moreover, 6PP3-PNP exhibited excellent biocompatibility both in vitro and in vivo. These findings elucidate the structure-function relationship of hydrophobized PEI in mRNA delivery and demonstrate a tunable strategy for developing organ-selective carriers, thereby expanding the potential of mRNA therapeutics for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyethyleneimineRNA, MessengerNanoparticlesSpleenPolymersAnimalsMiceGene Transfer TechniquesHumansTransfection

Stichwörter der Autor:innen

mRNA deliveryorgan-selectivepolyethyleniminepolymeric nanoparticlesspleen

Substanzen

PolyethyleneimineRNA, MessengerPolymers

Autor:innen und Institutionen

  • Shandong Academy of Pharmaceutical Sciences, Jinan 250101, China.
  • Department of Urology, Qilu Hospital of Shandong University, Jinan 250014, China.
  • Shandong Engineering Research Center of New Sustained and Controlled Release Formulations and Drug Targeted Delivery Systems, Jinan 250101, China.

ORCID-Profile: Hongqian Zhang

Förderung

  • Department of Science and Technology of Shandong Province
  • Postdoctoral Innovation Program of Shandong Province

Zitieren

APA

Zhang, H., Chen, D., Xue, S., Liu, Z., Yang, X., Zhang, C., Li, D., & Zhang, D. (2026). Engineered Polymeric Nanoparticles Based on Arylated Polyethylenimine Enable Spleen-Selective mRNA Delivery. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01272

Vancouver

Zhang H, Chen D, Xue S, Liu Z, Yang X, Zhang C, et al. Engineered Polymeric Nanoparticles Based on Arylated Polyethylenimine Enable Spleen-Selective mRNA Delivery. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01272

BibTeX
@article{Zhang2026,
  author = {Zhang, Hongqian and Chen, Dongshan and Xue, Song and Liu, Zhengping and Yang, Xuehua and Zhang, Cong and Li, Dawei and Zhang, Daizhou},
  title = {Engineered Polymeric Nanoparticles Based on Arylated Polyethylenimine Enable Spleen-Selective mRNA Delivery},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01272}
}
Kostenlos starten →